KWMG
GILD icon

King Wealth Management Group’s Gilead Sciences GILD Stock Holding History

King Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
1,885
+160
+9% +$21.1K 0.03% 155
2026
Q1 		$240K Buy
1,725
+41
+2% +$5.74K 0.03% 143
2025
Q4 		$207K Sell
1,684
-428
-20% -$52K 0.02% 155
2025
Q3 		$234K Buy
2,112
+1
+0% +$114 0.03% 149
2025
Q2 		$234K Buy
2,111
+1
+0% +$106 0.03% 145
2025
Q1 		$236K Buy
+2,110
New +$218K 0.04% 136
2020
Q3 		– Sell
-2,704
Closed -$208K – 162
2020
Q2 		$208K Buy
2,704
+4
+0.1% +$307 0.06% 143
2020
Q1 		$202K Sell
2,700
-32,030
-92% -$2.21M 0.09% 126
2019
Q4 		$2.26M Sell
34,730
-596
-2% -$38.8K 0.6% 32
2019
Q3 		$2.24M Buy
35,326
+5,780
+20% +$378K 0.64% 31
2019
Q2 		$2M Sell
29,546
-3,030
-9% -$199K 0.6% 31
2019
Q1 		$2.12M Buy
32,576
+18,365
+129% +$1.22M 0.66% 32
2018
Q4 		$889K Buy
+14,211
New +$993K 0.32% 49

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

King Wealth Management Group's GILD Position: Q2 2026 in Review

King Wealth Management Group increased its Gilead Sciences (GILD) stake by 9.3% in Q2 2026, buying an estimated $21.1K and bringing the position to 1,885 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #155.

King Wealth Management Group first reported a position in GILD in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.26M in Q4 2019. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • King Wealth Management Group held 1,885 shares of Gilead Sciences worth $238K as of Q2 2026.
  • King Wealth Management Group bought 160 Gilead Sciences shares in Q2 2026, an estimated $21.1K.
  • Gilead Sciences made up 0.03% of King Wealth Management Group's portfolio in Q2 2026, its #155 holding.
  • King Wealth Management Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 13 quarters since.
  • King Wealth Management Group's Gilead Sciences position peaked at $2.26M in Q4 2019.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on King Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.